Your session is about to expire
← Back to Search
Efficacy of an Exercise Program for Patients With Femoro-acetabular Impingement
N/A
Waitlist Available
Led By Paul Beaule, MD, FRCSC
Research Sponsored by Ottawa Hospital Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Diagnosed with symptomatic FAI
at least 3 months of groin pain
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change in baseline before exercise program and 1 year afterwards
Awards & highlights
No Placebo-Only Group
Summary
This trial will test whether an exercise program can help reduce pain and improve function in people with FAI, as well as prevent further cartilage deterioration.
Who is the study for?
This trial is for individuals with femoroacetabular impingement (FAI) who have experienced groin pain for at least three months, feel more pain when their hip rotates, and have specific signs of FAI on imaging tests like an alpha angle over 60 degrees and a labral tear visible on MRI. Their condition should not be too advanced as indicated by a Tonnis grade of 0 or 1.
What is being tested?
The study is testing the effectiveness of an exercise program designed specifically for patients with FAI. It aims to see if this program can reduce their pain, improve how well they move and function, and possibly slow down any worsening of hip cartilage damage.
What are the potential side effects?
Since the intervention involves physical exercise, potential side effects may include muscle soreness, joint discomfort or temporary increase in existing pain due to activity. However, these are typically mild and manageable.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been diagnosed with symptomatic femoroacetabular impingement.
Select...
I have had groin pain for at least 3 months.
Select...
My hip joint shows minimal or no arthritis.
Select...
I experience more pain when my hip is turned.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change in baseline before exercise program and 1 year afterwards
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change in baseline before exercise program and 1 year afterwards
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
iHOT-33
Secondary study objectives
EQ-5D-5L
Number of participants that receive hip surgery
Patient-reported hip pain
Side effects data
From 2009 Phase 1 & 2 trial • 152 Patients • NCT008157767%
Discomfort or Pain
5%
Headache
100%
80%
60%
40%
20%
0%
Study treatment Arm
Clayton Intra-aural Device (CID) Group
Mouth Splint Group
Jaw Exercise Group
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Exercise GroupExperimental Treatment1 Intervention
The group who will exercise to manage pain.
Group II: Control GroupActive Control1 Intervention
The group who will not take part in any exercises and only have to do assessments.
Find a Location
Who is running the clinical trial?
Ottawa Hospital Research InstituteLead Sponsor
576 Previous Clinical Trials
3,139,833 Total Patients Enrolled
Canadian Orthopaedic FoundationOTHER
14 Previous Clinical Trials
1,541 Total Patients Enrolled
Paul Beaule, MD, FRCSCPrincipal InvestigatorOttawa Hospital Research Institute
2 Previous Clinical Trials
83 Total Patients Enrolled